Vaccination Study Guide

📖 Core Concepts Vaccination – giving a vaccine (live‑attenuated, killed, protein, or toxin) to train the adaptive immune system to recognize a pathogen. Herd immunity – when enough people are immune, transmission drops, protecting those who can’t be vaccinated (e.g., immunocompromised). Primary vaccine failure – the immune system fails to make protective antibodies after the first dose. Sterilizing immunity – vaccine prevents infection entirely (e.g., smallpox). Disease‑severity immunity – vaccine mainly reduces the chance of severe illness, not infection (e.g., most COVID‑19 vaccines). Adjuvant – an ingredient (e.g., aluminium salts) that boosts the immune response to the antigen. --- 📌 Must Remember Vaccination prevents 3.5–5 million deaths/year worldwide (WHO). From 1974‑2024, ≈154 million deaths averted (≈146 million under‑5). Serious adverse events ≈ 1 per 100 000 vaccinations (usually allergic). Thimerosal = ethylmercury, cleared faster than methylmercury; no proven link to autism. Jacobson v. Massachusetts (1905) – Supreme Court upheld compulsory vaccination for public‑health protection. Herd immunity threshold varies by disease; higher for more contagious pathogens (e.g., measles ≈ 95%). --- 🔄 Key Processes Vaccination → Antigen presentation – APCs take up vaccine antigens → display on MHC → activate T‑cells. Adaptive response – Helper T‑cells stimulate B‑cells → produce specific antibodies; memory B/T cells form. Immunity timeline – Protective antibodies develop weeks after vaccination; passive antibodies (e.g., from breast milk) act immediately. Post‑exposure prophylaxis (e.g., rabies) – Immediate wound care + rabies immune globulin + vaccine series over 14 days. Fractional dosing – Reduce dose per person → vaccinate more individuals when supply limited (used for COVID‑19, poverty‑related diseases). --- 🔍 Key Comparisons Live‑attenuated vs. Inactivated/Killed Live‑attenuated: replicates in host, often oral (polio, rotavirus); induces strong, long‑lasting immunity. Inactivated/Killed: cannot replicate, usually injected; may need boosters. Sterilizing immunity vs. Disease‑severity immunity Sterilizing: blocks infection entirely (smallpox). Severity: reduces complications but infection can still occur (most COVID‑19 vaccines). Primary vaccine failure vs. Secondary (waning) failure Primary: no antibody response after initial dose. Secondary: antibodies decline over time; booster needed. Injection vs. Oral/Intranasal delivery Injection: most reliable absorption; IM, SC, ID routes. Oral/Intranasal: targets mucosal immunity; useful for gut pathogens (oral polio) or respiratory viruses. --- ⚠️ Common Misunderstandings “Vaccines cause autism.” – No credible evidence; the Wakefield study was falsified and retracted. “If I get a mild side effect, the vaccine is dangerous.” – Soreness/low‑grade fever are common, mild, and indicate immune activation. “One dose guarantees lifelong immunity.” – Some vaccines require boosters; immunity can wane (secondary failure). “All side effects are serious.” – Serious reactions occur in 1/100 000; most are minor and self‑limited. --- 🧠 Mental Models / Intuition “Training wheels” model – Vaccines are like practice runs for the immune system; the real pathogen is the “road” the body later navigates safely. “Firebreak” analogy for herd immunity – Immunized individuals act as firebreaks, stopping the spread of the “flame” (infection) to vulnerable people. “Signal amplification” with adjuvants – Think of adjuvants as a megaphone that makes the immune “voice” louder, creating a stronger memory. --- 🚩 Exceptions & Edge Cases Oral vaccines may be ineffective if the gut environment is compromised (e.g., severe diarrhea). Immunocompromised patients may receive live‑attenuated vaccines only after risk–benefit assessment. Thimerosal‑containing multi‑dose vials are safe; however, single‑dose vials avoid any preservative exposure. Fractional dosing may not achieve sterilizing immunity; it is primarily used to expand coverage during shortages. --- 📍 When to Use Which Choose oral or intranasal when mucosal immunity is critical (e.g., rotavirus, influenza nasal spray). Select live‑attenuated for strong, long‑lasting immunity if the recipient is immunocompetent. Use inactivated/killed or subunit vaccines for immunocompromised or pregnant patients. Apply fractional dose during vaccine shortages or for mass campaigns where some protection is better than none. Add aluminium adjuvant when antigen is weakly immunogenic (e.g., hepatitis B). --- 👀 Patterns to Recognize Side‑effect pattern: local pain → mild fever → resolves in 1‑3 days → indicates normal response. Failure pattern: no seroconversion after first dose → consider primary failure → schedule booster. Herd‑immunity signal: sudden drop in cases after >90 % coverage in a community. Policy impact pattern: introduction of school‑entry mandates → rapid increase in coverage rates. --- 🗂️ Exam Traps Distractor: “Vaccines always provide sterilizing immunity.” – Wrong; many only reduce severity. Trap: “Thimerosal causes autism.” – Incorrect; no causal link. Mislead: “Passive immunity lasts as long as active immunity.” – False; passive immunity is short‑lived (weeks). Choice error: Selecting “oral route is always preferred” – Not true; injection remains the most reliable for most vaccines. Pitfall: Assuming “primary vaccine failure” means the vaccine is defective – Actually, it reflects individual immune variability.